Full video transcriptClick to expand
Auto-generated transcript of @kweennx2fit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Look what I found y'all who are my GLP one girlies. You have to make sure you're taking your supplements
GLP-1 and vitamins: what the TikTok hype gets wrong
Quick answer
GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and caloric intake, which can lead to micronutrient deficiencies over time, particularly in patients losing weight rapidly. Clinical monitoring for deficiencies in vitamin B12, vitamin D, iron, and protein adequacy is increasingly recommended by obesity medicine specialists, though formal GLP-1-specific supplementation guidelines remain limited. Patients should have individualized bloodwork reviewed before starting supplementation regimens rather than following generalized social media advice.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 and vitamins: what the TikTok hype gets wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GLP-1 and vitamins: what the TikTok hype gets wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GLP-1 and vitamins: what the TikTok hype gets wrong" from Kweenn. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and caloric intake, which can lead to micronutrient deficiencies over time, particularly in patients losing weight rapidly.
The reason this review is not generic is the source wording and the canonical claim label "glp1 the goat glp1community fyp vitamins followmyjourney." In this clip, the useful excerpt is: "Look what I found y'all who are my GLP one girlies." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and caloric intake, which can lead to micronutrient deficiencies over time, particularly in patients losing weight rapidly.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and caloric intake, which can lead to micronutrient deficiencies over time, particularly in patients losing weight rapidly. Clinical monitoring for deficiencies in vitamin B12, vitamin D, iron, and protein adequacy is increasingly recommended by obesity medicine specialists, though formal GLP-1-specific supplementation guidelines remain limited. Patients should have individualized bloodwork reviewed before starting supplementation regimens rather than following generalized social media advice.
- GLP-1 medications reduce appetite enough that micronutrient intake can drop significantly, a concern supported by data from analogous bariatric surgery research (Mechanick et al., 2020, Obesity).
- Vitamin B12 deficiency is a particular risk for GLP-1 users also taking metformin, since metformin independently reduces B12 absorption (de Jager et al., 2010, BMJ).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- GLP-1 medications reduce appetite enough that micronutrient intake can drop significantly, a concern supported by data from analogous bariatric surgery research (Mechanick et al., 2020, Obesity).
- Vitamin B12 deficiency is a particular risk for GLP-1 users also taking metformin, since metformin independently reduces B12 absorption (de Jager et al., 2010, BMJ).
- Protein intake matters as much as micronutrients. Studies on GLP-1 therapy show lean muscle mass loss alongside fat loss, and adequate dietary protein helps reduce this (Biermann et al., 2022, Journal of Clinical Endocrinology and Metabolism).
- No universal supplement protocol exists specifically for GLP-1 users. Current guidance is largely extrapolated from bariatric and very-low-calorie-diet literature, not GLP-1-specific trials.
- Vitamin D deficiency is common in people with obesity before they even start a GLP-1 medication, meaning it may predate the drug rather than result from it.
- Bloodwork is the only reliable way to know whether you actually need a supplement. A standard panel checking B12, vitamin D, iron, ferritin, and a complete metabolic panel is a reasonable starting point to discuss with your prescriber.
- Social media supplement recommendations, even from well-intentioned creators in the GLP-1 community, are not a substitute for individualized medical or dietitian guidance.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kweennx2fit actually say?
Not much, honestly. The creator said, "you have to make sure you're taking your supplements" while apparently showing a product to her 1.2 million viewers. That's the entire medical claim here. No specific supplements named, no dosages, no explanation of why. It's vague enough that it's hard to call wrong, but it's also vague enough to be potentially misleading depending on what she was holding up.
The GLP-1 community on TikTok has built a whole supplement culture around semaglutide and tirzepatide use. Some of it is grounded in real nutritional concerns. Some of it is people selling things. Without knowing what product she's showing, we're fact-checking the general claim that GLP-1 users need supplements, which is actually worth examining on its own.
Does the science back this up?
Yes, with significant caveats. GLP-1 receptor agonists reduce appetite substantially, which means people eat less. Eating less means taking in fewer micronutrients. That part is well-established and clinically relevant, not just influencer talk.
A 2023 review by Wilding et al. in Diabetes, Obesity and Metabolism noted that patients on semaglutide in the STEP trials lost significant lean muscle mass alongside fat, raising concerns about protein adequacy. Separately, research on post-bariatric patients, who experience similar dramatic caloric restriction, consistently shows deficiencies in vitamin B12, iron, vitamin D, and folate (Mechanick et al., 2020, Obesity). GLP-1 clinicians have started applying similar nutritional monitoring logic to their patients, though the evidence base specific to GLP-1 drugs is still catching up to clinical practice. The concern is legitimate. The prescription to just "take your supplements" is too blunt to be useful.
What did they get wrong (or right)?
She got the general direction right. GLP-1 users do face real nutritional risks that most people, and frankly many prescribers, underestimate. That's worth saying out loud.
What she got wrong, or at least incomplete, is the implication that supplements are a simple fix. The word "have to" implies a universal rule. It isn't one. Someone using a GLP-1 medication at a modest dose with a nutritionally dense diet and no underlying absorption issues may not need supplementation at all. Someone losing weight rapidly on tirzepatide while barely eating probably does. The difference matters.
There's also the muscle mass problem. Protein intake during GLP-1 therapy is arguably more important than any vitamin. A 2022 study by Biermann et al. in The Journal of Clinical Endocrinology and Metabolism found that adequate dietary protein helped preserve lean mass during weight loss interventions. Supplements like a multivitamin won't address that. Generic supplement advice without context about protein, caloric adequacy, and individual bloodwork is half a conversation.
What should you actually know?
If you're on a GLP-1 medication and eating significantly less than you used to, your micronutrient intake deserves attention. That's not alarmism, it's basic math. But the right answer isn't to grab whatever a TikTok creator is holding up to the camera.
The supplements most consistently flagged in clinical guidance for people on low-calorie regimens include:
- Vitamin B12, especially for those on metformin alongside GLP-1 drugs, since metformin independently depletes B12 (de Jager et al., 2010, BMJ)
- Vitamin D, which is commonly deficient in people with obesity independent of GLP-1 use
- Calcium, particularly if dairy intake drops
- Iron, especially in premenopausal women eating less red meat
None of this should come from a TikTok video. Get bloodwork. Talk to your prescriber or a registered dietitian who has actual experience with GLP-1 patients. The supplement industry does not need more customers buying random products because a viral video said "you have to."
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Kweenn · TikTok creator
1.2M views on this video
The GOAT! 🐐 #glp1community #fyp #vitamins #followmyjourney❤️
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about glp-1 medications reduce appetite enough?
GLP-1 medications reduce appetite enough that micronutrient intake can drop significantly, a concern supported by data from analogous bariatric surgery research (Mechanick et al., 2020, Obesity).
What does the video say about vitamin b12 deficiency?
Vitamin B12 deficiency is a particular risk for GLP-1 users also taking metformin, since metformin independently reduces B12 absorption (de Jager et al., 2010, BMJ).
What does the video say about protein intake matters as much as micronutrients. studies on glp-1?
Protein intake matters as much as micronutrients. Studies on GLP-1 therapy show lean muscle mass loss alongside fat loss, and adequate dietary protein helps reduce this (Biermann et al., 2022, Journal of Clinical Endocrinology and Metabolism).
What does the video say about no universal supplement protocol exists specifically for glp-1 users. current?
No universal supplement protocol exists specifically for GLP-1 users. Current guidance is largely extrapolated from bariatric and very-low-calorie-diet literature, not GLP-1-specific trials.
What does the video say about vitamin d deficiency?
Vitamin D deficiency is common in people with obesity before they even start a GLP-1 medication, meaning it may predate the drug rather than result from it.
What does the video say about bloodwork?
Bloodwork is the only reliable way to know whether you actually need a supplement. A standard panel checking B12, vitamin D, iron, ferritin, and a complete metabolic panel is a reasonable starting point to discuss with your prescriber.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Kweenn, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.